BIOXYTRAN, INC - FORM S-1 - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - June 24, 2021

Attached files

file filename
S-1 - FORM S-1 - BIOXYTRAN, INCn2583-x5_s1.htm
EX-10.62 - 2017 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (SUBSIDIARY), ADOPTED BY THE B - BIOXYTRAN, INCexh10-62.htm
EX-10.61 - 2021 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN, ADOPTED BY THE BOARD OF DIREC - BIOXYTRAN, INCexh10-61.htm
EX-10.60 - LICENSE AGREEMENT BETWEEN PHARMALECTIN, INC. AND NDPD PHARMA, INC. DATED MAY 2, - BIOXYTRAN, INCexh10-60.htm
EX-10.59 - LICENSE AGREEMENT BETWEEN BIOXYTRAN, INC. AND PHARMALECTIN, INC. DATED MAY 5, 20 - BIOXYTRAN, INCexh10-59.htm

Exhibit 23.1

 

To Whom It May Concern:

 

We hereby consent to the incorporation of our report dated April 9, 2021, with respect to the financial statements of Bioxytran, Inc. for the years ended December 31, 2020 and 2019, included in the Registration Statement of Bioxytran, Inc. on Form S-1 to be filed on or about June 23, 2021.  We also consent to the use of our name and the references to us included in the Registration Statement.

 

 

/s/ Pinnacle Accountancy Group of Utah           

 

Pinnacle Accountancy Group of Utah

(a dba of Heaton & Company, PLLC)

Farmington, Utah

June 23, 2021

 

 

   

 

BIOXYTRAN, INC Reports